How long must women of childbearing potential and men with female partners of childbearing potential use contraception after belantamab mafodotin (Blenrep) treatment?

Women of childbearing potential must use effective contraception during belantamab mafodotin (Blenrep) treatment and for at least 4 months after the last dose; men with female partners of childbearing potential must do so during treatment and for at least 6 months after the last dose.